Signaling Pathways - LRRK2 - Neuraminidases (NA) - Insulin and Insulin-like Receptors - Protease-Activated Receptors
清除全部
- B4635 CZC-25146Target: LRRK2Summary: LRRK2抑制剂
- B4633 GNE0877Target: LRRK2Summary: LRRK2抑制剂
- B3605 GNE-7915Target: LRRK2Summary: LRRK2抑制剂
- B1803 Oseltamivir phosphate1 Citation中文名: 磷酸奥司他韦Target: Neuraminidases (NA)Summary: 有效的选择性神经氨酸酶抑制剂
- B1262 HG-10-102-011 CitationTarget: LRRK2Summary: LRRK2抑制剂
- A8809 Vorapaxar中文名: 沃拉帕沙Target: Protease-Activated ReceptorsSummary: PAR-1拮抗剂
- A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂
- A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: IGF-1R/IR 选择性抑制剂
- A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: 有效的、选择性的IGF-1R和InsR抑制剂
- A8229 ML161Target: Protease-Activated ReceptorsSummary: PAR1抑制剂